Literature DB >> 1762101

Atomic bomb and leukemia.

M Ichimaru1, M Tomonaga, T Amenomori, T Matsuo.   

Abstract

Characteristic features of leukemia among atomic bomb survivors were studied. The ratio of a single leukemia type to all leukemias was highest for CML in Hiroshima, and the occurrence of CML was thought to be most characteristic for atomic bomb radiation induced leukemia. In the distribution of AML subtypes of FAB classification, there was no M3 cases in 1Gy or more group, although several atypical AML cases of survivors were observed. Chromosome study was conducted using colony forming cells induced by hemopoietic stem cells of peripheral blood of proximal survivors. Same chromosome aberrations were observed in colony forming cells and peripheral blood of proximal survivors.

Entities:  

Mesh:

Year:  1991        PMID: 1762101     DOI: 10.1269/jrr.32.supplement_162

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  4 in total

1.  Calorie restriction reduces the incidence of myeloid leukemia induced by a single whole-body radiation in C3H/He mice.

Authors:  K Yoshida; T Inoue; K Nojima; Y Hirabayashi; T Sado
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 2.  Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.

Authors:  Christian Sillaber; Matthias Mayerhofer; Hermine Agis; Verena Sagaster; Christine Mannhalter; Wolfgang R Sperr; Klaus Geissler; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

Review 3.  Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.

Authors:  Afaf E G Osman; Michael W Deininger
Journal:  Blood Rev       Date:  2021-03-16       Impact factor: 10.626

4.  Induction of BCR-ABL fusion genes by in vitro X-irradiation.

Authors:  T Ito; T Seyama; T Mizuno; T Hayashi; K S Iwamoto; K Dohi; N Nakamura; M Akiyama
Journal:  Jpn J Cancer Res       Date:  1993-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.